# Wumeiwan Jiawei Fang Use in Patients With Blepharospasm

> **NCT05618470** · PHASE2,PHASE3 · UNKNOWN · sponsor: **China Academy of Chinese Medical Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Dry Eye Syndromes
- Meige Syndrome
- Blepharospasm
- Hyperactivity

## Interventions

- **DRUG:** Wumeiwan Jiawei Fang
- **DRUG:** botulinum toxin A

## Key facts

- **NCT ID:** NCT05618470
- **Lead sponsor:** China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-12
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05618470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05618470, "Wumeiwan Jiawei Fang Use in Patients With Blepharospasm". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05618470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*